Beam Therapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Beam Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Beam Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Beam Therapeutics by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $9.9M | 300k | 33.04 |
| 2022-03-31 | $5.2M | 90k | 57.30 |
| 2021-12-31 | $40M | 500k | 79.69 |
| 2021-09-30 | $8.7M | 100k | 87.01 |
| 2021-06-30 | $13M | 100k | 128.71 |
| 2021-03-31 | $14M | 172k | 80.04 |
| 2020-12-31 | $76M | 924k | 81.64 |
| 2020-09-30 | $20M | 796k | 24.62 |
| 2020-06-30 | $22M | 796k | 27.67 |
| 2020-03-31 | $14M | 796k | 18.00 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management